MENU
MDXG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MiMedx Group (MDXG) Ownership - Who owns MiMedx Group?
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
949.72M
P/E Ratio
23.81
Total Cash
106.43M
Projected Growth
N/A
Total Debt
18.66M
Revenue
352.38M
Risk (Beta)
1.48
Dividend Yield
N/A
Total Cash/Share
0.72
Total Debt/Equity
N/A
Revenue/Share
2.37 USD as % of share price
Fundamentals
MDXG
Capitalization
950M
P/E Ratio
23.81
Risk (Beta)
1.48
Dividend Yield
N/A
Total Cash
106M
Total Cash/Share
0.72
Total Debt
18.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.37%
Revenue
352M
ROE
N/A
Book Value
203M
P/B Ratio
4.68
Cash Flow
N/A
Earnings
0.28
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
148K
Current Ratio
4.70
Current Revenue Per Employee
105382.32
Dividends Per Share - Security
N/A
EBITDA
62.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
81.23
Revenue To Assets
16.33
Shares Held By Institutions
1.17B
Shares Outstanding - Current
148M
Total Liabilities
67.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-33.160
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of patent protected regenerative biomaterial products and bioimplants
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1775 West Oak Commons Court, NE
Phone
+1 770 651-9100
Employees
895
Web
https://www.mimedx.com